À§ ±â´É º¸Á¸ ¼ö¼ú¿¡ ¾ÕÀå
Á¶±â À§¾Ï ȯÀÚÀÇ »îÀÇ ÁúÀ» ³ôÀ̱â À§ÇÑ À§±â´É º¸Á¸ ¼ö¼ú¿¡ °ü½ÉÀÌ ¸¹¾Æ, ¡®À§±â´É º¸Á¸ À§ÀýÁ¦¼ú¡¯ ´Ù±â°ü ¿¬±¸¿¡ Âü¿©¸¦ Çß´Ù.
À§±â´É º¸Á¸ ¼ö¼úÀº ¸ðµç ȯÀÚ¿¡°Ô ´Ù Àû¿ëÇÒ ¼ö ÀÖ´Â °ÍÀº ¾Æ´Ï°í È¿°ú¸¦ º¼¸¸ÇÑ È¯ÀÚ¸¦ Àß Ã£´Â °Ô Áß¿äÇÏ´Ù. ¿Ü°úÀÇ»çÀÇ ¼ú±â ¿ª½Ã ÁÁ¾Æ¾ß ÇÑ´Ù. ´ëÇѿܰúÇÐȸ ÆíÁýÀ§¿ø, ´ëÇÑÀ§¾ÏÇÐȸ ÆíÁýÀ§¿ø, Çѱ¹º¸°ÇÀÇ·á ½ÅÀÇ·á±â¼ú Æò°¡À§¿øÀ¸·Î Ȱµ¿Çϰí ÀÖÀ¸¸ç ¡®À§¾ÏȯÀÚ¿¡¼ TIG1 À¯ÀüÀÚÀÇ ¹ßÇö ¹× º¯ÀÌ¡¯¶ó´Â ³í¹®À¸·Î ´ë¾ÏÀ§¾ÏÇÐȸ ¿ì¼ö¹ßÇ¥³í¹®»óÀ» ¹Þ¾Ò´Ù.
Á¦ ¸ñ | Oncologic Outcomes after Laparoscopic and Open Distal Gastrectomy for Advanced Gastric Cancer: Propensity Score Matching Analysis | ||
---|---|---|---|
¹ßÇ¥³âµµ | 2019.03 | ¹ßÇ¥Áö |
Á¦ ¸ñ | Recurrent gastric neuroendocrine tumors treated with total gastrectomy | ||
---|---|---|---|
¹ßÇ¥³âµµ | 2015.12 | ¹ßÇ¥Áö |
Á¦ ¸ñ | Clinical features of second primary cancers arising in early gastric cancer patients after endoscopic resection | ||
---|---|---|---|
¹ßÇ¥³âµµ | 2015.07 | ¹ßÇ¥Áö |
Á¦ ¸ñ | The Effects of Broccoli Sprout Extract Containing Sulforaphane on Lipid Peroxidation and Helicobacter pylori Infection in the Gastric Mucosa | ||
---|---|---|---|
¹ßÇ¥³âµµ | 2015.07 | ¹ßÇ¥Áö |
Á¦ ¸ñ | Acute phlegmonous gastritis complicated by delayed perforation | ||
---|---|---|---|
¹ßÇ¥³âµµ | 2014.03 | ¹ßÇ¥Áö |
Á¦ ¸ñ | Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial | ||
---|---|---|---|
¹ßÇ¥³âµµ | 2012.01 | ¹ßÇ¥Áö |
Á¦ ¸ñ | Neuroendocrine Tumor of Unknown Primary Accompanied with Stomach Adenocarcinoma | ||
---|---|---|---|
¹ßÇ¥³âµµ | 2011.12 | ¹ßÇ¥Áö |
À§¾ÏÀ¸·Î ÀÎÇÑ À§ÀýÁ¦¼ú ÈÄ ¹ß»ýÇÏ´Â ¿µ¾ç ¼·Ãë ¹®Á¦ µîÀÇ ÇØ°á ¹æ¹ý°ú ¼ö¼ú ÈÄ Ç×¾Ï Ä¡·á¸¦ Àß ¹ÞÀ» ¼ö ÀÖ°Ô ÇÏ´Â ºÐ¾ß¿¡ °ü½ÉÀ» °¡Áö°í ÀÖ½À´Ï´Ù.
¼ö¼ú ÈÄ ½ÅüÀû, Á¤½ÅÀûÀ¸·Î ¿©·¯°¡Áö ºÒÆíÇÑ Á¡ÀÌ ¸¹ÀÌ »ý±é´Ï´Ù.¿ì¼± Áø·áÁøÀÇ ¼³¸íÀ» Àß µè°í, Çâ ÈÄ Ä¡·á¿¡ Àû±ØÀûÀ¸·Î Âü¿©ÇϼÌÀ¸¸é ÇÕ´Ï´Ù. ±×¸®°í ÁÖ±âÀûÀÎ ÁøÂû°ú °Ë»ç¸¦ ¹Þ´Â °ÍÀÌ ÁÁ½À´Ï´Ù.
À§¾ÏÀ¸·Î À§ÀýÁ¦¼úÀ» ¹ÞÀ¸½Å ÈÄ¿¡µµ ÀÏ»ó»ýȰÀº °¡´ÉÇÕ´Ï´Ù. ±×·¯³ª ½ÄÀÌ ¼·Ãë ¹× ½ÅüÀûÀ¸·Î ¾à°£ÀÇ ºÒÆíÀº ÀÖÀ» ¼ö ÀÖÀ¸³ª, Á¤½ÅÀûÀ¸·Î ¾ÏÀ» À̰ܳ¾ ¼ö ÀÖ´Ù´Â ±àÁ¤ÀûÀÎ »ý°¢À» °¡Áö°í »ýȰÀ» ÇÏ½Ã¸é µË´Ï´Ù. ¶ÇÇÑ, ±Ý¿¬ ¹× ±ÝÁÖ¿Í ´õºÒ¾î ½Ä»ýȰ °³¼±¿¡ ³ë·ÂÀ» ÇÏ½Ã¸é ´õ¿í ´õ ÁÁÀ» µí ÇÕ´Ï´Ù.
°æÈñ´ëÇб³º´¿øÀº ȯÀÚ Áß½ÉÀÇ ÀÇ·á ¼ºñ½º¸¦ Á¦°øÇϸç, ±¹³» ÀÇ·á°è¸¦ ¼±µµÇÏ´Â »ó±ÞÁ¾ÇÕº´¿øÀÔ´Ï´Ù. ÃֽŠÀÇ·á ±â¼ú°ú Àåºñ¸¦ Ȱ¿ëÇÏ¿© ȯÀڵ鿡°Ô ÃÖ»óÀÇ Ä¡·á¸¦ Á¦°øÇÕ´Ï´Ù. ƯÈ÷ ÁßÁõÁúȯ Ä¡·á ¹× ¿¬±¸¿¡ °Á¡À» º¸À̸ç, ´ÙÇÐÁ¦ ÇùÁø ½Ã½ºÅÛÀ» ÅëÇØ ȯÀÚÀÇ °Ç°À» ÃÖ¿ì¼±À¸·Î »ý°¢ÇÕ´Ï´Ù. °æÈñ´ëÇб³º´¿øÀº ȯÀÚµéÀÇ ½Å·Ú¿Í ¸¸Á·µµ¸¦ ³ôÀÌ´Â µ¥ ÁÖ·ÂÇϸç, Áö¼ÓÀûÀ¸·Î ÀÇ·á ǰÁú Çâ»ó°ú ¿¬±¸ °³¹ß¿¡ Èû¾²°í ÀÖ½À´Ï´Ù.
¼¿ïƯº°½Ã µ¿´ë¹®±¸ °æÈñ´ë·Î 23 °æÈñ´ëÇб³º´¿ø